Designing hybrid onconase nanocarriers for mesothelioma therapy: a Taguchi orthogonal array and multivariate component driven analysis.

Tekade RK, Youngren-Ortiz SR, Yang H, Haware R, Chougule MB. Designing hybrid onconase nanocarriers for mesothelioma therapy: a Taguchi orthogonal array and multivariate component driven analysis. Mol Pharm. 2014 Oct 06; 11(10):3671-83.

View in: PubMed

subject areas

Cell Line, Tumor
Cell Survival
Drug Carriers
Humans
Lung Neoplasms
Mesothelioma
Multivariate Analysis
Nanoparticles
Polymerase Chain Reaction

authors with profiles

Mahavir Chougule, PhD, MPharm, B Pharm

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support